Iovance Biotherapeutics, Inc. (FRA:2LB)
Germany · Delayed Price · Currency is EUR 2.087
+0.002 (0.10%)
At close: Nov 28, 2025
Iovance Biotherapeutics Market Cap
Iovance Biotherapeutics has a market cap or net worth of €761.48 million as of December 2, 2025. Its market cap has decreased by -70.64% in one year.
Market Cap
761.48M
Enterprise Value
547.89M
Revenue
213.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
€2.09
Market Cap Chart
Since May 26, 2010, Iovance Biotherapeutics's market cap has increased from 73.63M to 761.48M, an increase of 934.27%. That is a compound annual growth rate of 16.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 761.48M | -65.05% |
| Dec 31, 2024 | 2.18B | 15.73% |
| Dec 29, 2023 | 1.88B | 99.45% |
| Dec 30, 2022 | 943.75M | -64.17% |
| Dec 31, 2021 | 2.63B | -52.67% |
| Dec 31, 2020 | 5.56B | 78.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |